Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514456, A61K 3140, A61K 3135

Patent

active

056961499

ABSTRACT:
The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifiuoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders.

REFERENCES:
patent: 3822287 (1974-07-01), Bolger
patent: 4447622 (1984-05-01), Salman et al.
patent: 5280040 (1994-01-01), Labroo et al.
patent: 5451603 (1995-09-01), Piggott
patent: 5480903 (1996-01-01), Piggott
Ray et al. "An X-ray Crytallographic Study of the Nonsteroidal Contraceptive Agent Centchroman", J. Med. Chem. Soc., vol. 37, pp. 696-700 (1993) 1994.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3,4-diphenyl chromans for the manufacture of a pharmaceut will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1608115

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.